We intend to commercialize our products in Europe and the U.S. using a specialist sales team targeting gastroenterologists in hospitals and specialists care centres. We plan to partner with established pharmaceutical companies to commercialize products in the rest of the world.

We have developed a broad later stage clinical pipeline offering risk diversification, targeting multiple patient groups.

​To find out more or discuss investment opportunities, please make contact through investors@atlantichc.com